Analysts Issue Forecasts for Pro-Dex Q4 Earnings

Pro-Dex, Inc. (NASDAQ:PDEX) – Equities researchers at Ascendiant Capital Markets issued their Q4 2026 earnings per share estimates for Pro-Dex in a research report issued on Monday, May 11th. Ascendiant Capital Markets analyst E. Woo anticipates that the medical instruments supplier will post earnings of $0.67 per share for the quarter. Ascendiant Capital Markets has a “Buy” rating and a $70.00 price objective on the stock.

Separately, Weiss Ratings reissued a “hold (c+)” rating on shares of Pro-Dex in a research note on Friday, May 1st. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, Pro-Dex has an average rating of “Moderate Buy” and a consensus target price of $70.00.

Pro-Dex Stock Performance

NASDAQ:PDEX opened at $57.44 on Thursday. The company has a quick ratio of 2.14, a current ratio of 3.67 and a debt-to-equity ratio of 0.32. Pro-Dex has a twelve month low of $23.47 and a twelve month high of $61.62. The company has a fifty day moving average of $50.68 and a 200-day moving average of $42.67. The firm has a market capitalization of $183.41 million, a P/E ratio of 15.87 and a beta of -0.12.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Thursday, April 30th. The medical instruments supplier reported $1.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.58. The firm had revenue of $19.95 million for the quarter, compared to analyst estimates of $17.90 million. Pro-Dex had a return on equity of 22.78% and a net margin of 16.08%.

Institutional Investors Weigh In On Pro-Dex

Hedge funds have recently added to or reduced their stakes in the company. Los Angeles Capital Management LLC bought a new stake in shares of Pro-Dex during the fourth quarter valued at approximately $37,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Pro-Dex in the 2nd quarter worth $50,000. Bank of America Corp DE grew its position in Pro-Dex by 173.3% in the 2nd quarter. Bank of America Corp DE now owns 1,692 shares of the medical instruments supplier’s stock valued at $74,000 after purchasing an additional 1,073 shares during the period. AlphaQuest LLC acquired a new stake in Pro-Dex in the 3rd quarter valued at $71,000. Finally, Wells Fargo & Company MN increased its stake in Pro-Dex by 65.4% during the 4th quarter. Wells Fargo & Company MN now owns 2,314 shares of the medical instruments supplier’s stock valued at $89,000 after purchasing an additional 915 shares in the last quarter. Institutional investors and hedge funds own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc is a designer and manufacturer of precision drive systems and fluid management products serving the dental, medical, industrial and energy markets. The company specializes in high-speed, brushless micromotors and controllers, as well as pneumatic and fluid control devices, providing both standard and custom-engineered solutions for original equipment manufacturers.

Its product portfolio includes high-speed dental handpieces, turbine systems, rotary and reciprocating micro-drives, along with integrated fluid delivery systems.